134 related articles for article (PubMed ID: 15742820)
1. Surfactant effects upon dissolution patterns of carbamazepine immediate release tablet.
Lee H; Park SA; Sah H
Arch Pharm Res; 2005 Jan; 28(1):120-6. PubMed ID: 15742820
[TBL] [Abstract][Full Text] [Related]
2. In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers.
Lake OA; Olling M; Barends DM
Eur J Pharm Biopharm; 1999 Jul; 48(1):13-9. PubMed ID: 10477323
[TBL] [Abstract][Full Text] [Related]
3. Discriminatory dissolution method for quality control measurements of carbamazepine immediate release tablets based on in vitro--in vivo investigations.
Xu C; Zou M; Wang Y; Liu Y; Yan J; Wu Y; Cheng G
Drug Dev Ind Pharm; 2012 Jun; 38(6):679-88. PubMed ID: 21988132
[TBL] [Abstract][Full Text] [Related]
4. Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate.
Crison JR; Weiner ND; Amidon GL
J Pharm Sci; 1997 Mar; 86(3):384-8. PubMed ID: 9050810
[TBL] [Abstract][Full Text] [Related]
5. Towards a universal dissolution medium for carbamazepine.
El-Massik MA; Abdallah OY; Galal S; Daabis NA
Drug Dev Ind Pharm; 2006 Aug; 32(7):893-905. PubMed ID: 16908426
[TBL] [Abstract][Full Text] [Related]
6. Applications of a new device (spindle) for improved characterization of drug release (dissolution) of pharmaceutical products.
Qureshi SA; Shabnam J
Eur J Pharm Sci; 2003 Jul; 19(4):291-7. PubMed ID: 12885394
[TBL] [Abstract][Full Text] [Related]
7. Mechanism for the Reduced Dissolution of Ritonavir Tablets by Sodium Lauryl Sulfate.
Guo Y; Wang C; Dun J; Du L; Hawley M; Sun CC
J Pharm Sci; 2019 Jan; 108(1):516-524. PubMed ID: 30389564
[TBL] [Abstract][Full Text] [Related]
8. Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in vitro drug release method.
Qiu Y; Garren J; Samara E; Cao G; Abraham C; Cheskin HS; Engh KR
J Pharm Sci; 2003 Nov; 92(11):2317-25. PubMed ID: 14603516
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro study of six carbamazepine products.
Mittapalli PK; Suresh B; Hussaini SS; Rao YM; Apte S
AAPS PharmSciTech; 2008; 9(2):357-65. PubMed ID: 18431676
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and selection of bio-relevant dissolution media for a poorly water-soluble new chemical entity.
Tang L; Khan SU; Muhammad NA
Pharm Dev Technol; 2001 Nov; 6(4):531-40. PubMed ID: 11775954
[TBL] [Abstract][Full Text] [Related]
11. In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants.
Shah VP; Konecny JJ; Everett RL; McCullough B; Noorizadeh AC; Skelly JP
Pharm Res; 1989 Jul; 6(7):612-8. PubMed ID: 2798311
[TBL] [Abstract][Full Text] [Related]
12. Contact Angle Measurements: an Alternative Approach Towards Understanding the Mechanism of Increased Drug Dissolution from Ethylcellulose Tablets Containing Surfactant and Exploring the Relationship Between Their Contact Angles and Dissolution Behaviors.
Liu T; Hao J; Yang B; Hu B; Cui Z; Li S
AAPS PharmSciTech; 2018 May; 19(4):1582-1591. PubMed ID: 29488194
[TBL] [Abstract][Full Text] [Related]
13. Choice of rotation speed (rpm) for bio-relevant drug dissolution testing using a crescent-shaped spindle.
Qureshi SA
Eur J Pharm Sci; 2004 Nov; 23(3):271-5. PubMed ID: 15489128
[TBL] [Abstract][Full Text] [Related]
14. The effects of surfactants on the solubility and dissolution profiles of a poorly water-soluble basic drug, carvedilol.
Incecayir T
Pharmazie; 2015 Dec; 70(12):784-90. PubMed ID: 26817275
[TBL] [Abstract][Full Text] [Related]
15. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
[TBL] [Abstract][Full Text] [Related]
16. Surfactant-mediated dissolution of metformin hydrochloride tablets: wetting effects versus ion pairs diffusivity.
Desai D; Wong B; Huang Y; Ye Q; Tang D; Guo H; Huang M; Timmins P
J Pharm Sci; 2014 Mar; 103(3):920-6. PubMed ID: 24549733
[TBL] [Abstract][Full Text] [Related]
17. A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions.
Rao VM; Lin M; Larive CK; Southard MZ
J Pharm Sci; 1997 Oct; 86(10):1132-7. PubMed ID: 9344170
[TBL] [Abstract][Full Text] [Related]
18. Drug dissolution into micellar solutions: development of a convective diffusion model and comparison to the film equilibrium model with application to surfactant-facilitated dissolution of carbamazepine.
Crison JR; Shah VP; Skelly JP; Amidon GL
J Pharm Sci; 1996 Sep; 85(9):1005-11. PubMed ID: 8877894
[TBL] [Abstract][Full Text] [Related]
19. Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release.
Marchais H; Cayzeele G; Legendre JY; Skiba M; Arnaud P
Eur J Pharm Sci; 2003 Jun; 19(2-3):129-32. PubMed ID: 12791415
[TBL] [Abstract][Full Text] [Related]
20. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
Javadzadeh Y; Mohammadi A; Khoei NS; Nokhodchi A
Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
